(Q50900611)

25 March 2018

title

Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML. (English)

1 reference

25 March 2018

author name string

K Takahashi

1

1 reference

25 March 2018

E Jabbour

2

1 reference

25 March 2018

X Wang

3

1 reference

25 March 2018

R Luthra

4

1 reference

25 March 2018

C Bueso-Ramos

5

1 reference

25 March 2018

K Patel

6

1 reference

25 March 2018

S Pierce

7

1 reference

25 March 2018

H Yang

8

1 reference

25 March 2018

Y Wei

9

1 reference

25 March 2018

N Daver

10

1 reference

25 March 2018

S Faderl

11

1 reference

25 March 2018

F Ravandi

12

1 reference

25 March 2018

Z Estrov

13

1 reference

25 March 2018

J Cortes

14

1 reference

25 March 2018

H Kantarjian

15

1 reference

25 March 2018

G Garcia-Manero

16

1 reference

25 March 2018

publication date

7 June 2013

1 reference

25 March 2018

published in

Leukemia

1 reference

25 March 2018

volume

27

1 reference

25 March 2018

issue

10

1 reference

25 March 2018

page(s)

2081-2083

1 reference

25 March 2018

https://scigraph.springernature.com/pub.10.1038/leu.2013.165

exact match

0 references

cites work

Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.165

Clonal architecture of secondary acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.165

The roles of FLT3 in hematopoiesis and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.165

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.165

FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.165

Prognostic impact of RAS mutations in patients with myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.165

Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.165

Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.165

Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up or acute myeloid leukaemia transformation: incidence and their prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.165

Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.165

A prognostic score for patients with lower risk myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.165

A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.165

inferred from DOI database lookup

7 January 2021

based on heuristic

Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.165

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2013.165

1 reference

25 March 2018

1 reference

25 March 2018